bosentan anhydrous has been researched along with cromakalim in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertini, M; Clement, MG | 1 |
| Chagneau, C; De Gottardi, A; Fléjou, JF; Fouassier, L; Housset, C; Lahaye, P; Lebrec, D; Moreau, R; Reichen, J; Rona, JP; Tazi, KA | 1 |
2 other study(ies) available for bosentan anhydrous and cromakalim
| Article | Year |
|---|---|
Hypoxic pulmonary vasoconstriction in pigs: role of endothelin-1, prostanoids and ATP-dependent potassium channels.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiac Output; Cromakalim; Cyclooxygenase Inhibitors; Endothelin-1; Female; Heart Rate; Hypoxia; Indomethacin; Male; Potassium Channels; Pulmonary Artery; Pulmonary Ventilation; Sulfonamides; Swine; Vascular Resistance; Vasoconstriction | 1998 |
Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosis.
Topics: Adenosine Triphosphate; Animals; Aorta; Bosentan; Cromakalim; Diazoxide; Endothelin-1; Endothelium, Vascular; Glyburide; Liver Cirrhosis, Experimental; Male; Membrane Potentials; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonamides; Tolbutamide | 1999 |